The stated terms project a 70% share of staking rewards for the fund, alongside a separate 1.10% annual sponsor charge and additional expenses.

Digital Currency
Canary Capital’s fund tied to staked Injective (INJ) has begun trading on Nasdaq.

The stated terms project a 70% share of staking rewards for the fund, alongside a separate 1.10% annual sponsor charge and additional expenses.
Steve McClurg said institutions may avoid obscure assets outside the top 20 without an ETF or a corporate treasury vehicle.
The chart shows INJ above a cup-and-handle pattern, with its breakout area near $6 under a support test.
The comparison sets $3.58 million in annual protocol revenue against a $1.11 billion valuation based on total supply and the Oct. 16 token price.